BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27492918)

  • 1. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiling of human cutaneous melanoma: are we there yet?
    Gershenwald JE; Bar-Eli M
    Cancer Biol Ther; 2004 Jan; 3(1):121-3. PubMed ID: 14764994
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.
    de Miera EV; Friedman EB; Greenwald HS; Perle MA; Osman I
    Pigment Cell Melanoma Res; 2012 May; 25(3):395-7. PubMed ID: 22404973
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis of Gene Expression for Melanoma Treatment.
    Kawakami A; Fisher DE
    J Invest Dermatol; 2016 Dec; 136(12):2342-2344. PubMed ID: 27884291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells to Surgery Quiz: October 2015.
    Aldahan AS; Mlacker S; Shah VV; Samarkandy S; Alsaidan M; Nouri K
    J Invest Dermatol; 2015 Oct; 135(10):e18. PubMed ID: 26358388
    [No Abstract]   [Full Text] [Related]  

  • 9. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
    Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
    Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
    Branca M; Orso S; Molinari RC; Xu H; Guerrier S; Zhang Y; Mili N
    Melanoma Res; 2018 Feb; 28(1):21-29. PubMed ID: 29194095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal MicroRNAs in Melanoma: A Mini-Review.
    Deng Z; Hao J; Lei D; He Y; Lu L; He L
    Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma progression, gene expression and DNA microarrays.
    Hoek KS
    G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes involved in the pathogenesis of cutaneous melanoma using bioinformatics analysis.
    Chen J; Sun W; Mo N; Chen X; Yang L; Tu S; Zhang S; Liu J
    J Int Med Res; 2020 Jan; 48(1):300060519895867. PubMed ID: 31937175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed genes in matched formalin-fixed paraffin-embedded primary and metastatic melanoma tumor pairs.
    Jewell R; Mitra A; Conway C; Iremonger J; Walker C; de Kort F; Cook M; Boon A; Speirs V; Newton-Bishop J
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):284-6. PubMed ID: 22212396
    [No Abstract]   [Full Text] [Related]  

  • 16. A marker for melanoma?
    Chande M
    Lancet; 2001 Aug; 358(9281):565. PubMed ID: 11520537
    [No Abstract]   [Full Text] [Related]  

  • 17. EGFR in melanoma: clinical significance and potential therapeutic target.
    Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
    J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.
    Zhang Z; Zhu S; Yang Y; Ma X; Guo S
    Tumour Biol; 2015 Nov; 36(11):8593-600. PubMed ID: 26040769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Genetic Expression Profiles in Melanoma Prognosis.
    Farberg AS; Glazer AM; Winkelmann RR; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):545-550. PubMed ID: 28886811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
    Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.